Since 2017, Our experienced team of neurologists and infusion care team has been safely providing IV infusions to Hawaii’s patients with neurological conditions at the state’s first & only Infusion Center specifically dedicated & designed to optimally care for patients with neurological conditions. Our onsite specialists are nationally recognized experts in neuroscience field and a pioneering leader & often FIRST in state & Pacific region to provide cutting edge research as well as FDA approved medications such as Aducanumab & Lecanemab.
→ Convenience of an outpatient setting in easy to get to central location in Honolulu (15 min from airport)
→ Easy parking and access to Infusion Center
→ Relaxed, comfortable outpatient setting : Reclining chair, TV (Netflix), Wi-Fi, snacks, privacy
→ On site experienced neurologists and care team to closely assess drug side-effect surveillance like ARIA and monitor long term clinical outcome for efficacy
→ On site specialized facilities including 3T MRI, CT, EEG, EMG for easy access for timely testing if needed
→ On site convenient labs and pharmacy
→ Concierge personalized patient care coordinator walking you through the process & financial counselor to look at ways to minimize out of pocket costs
→ Specialized drug & patient education provided by experienced neuroscience team in office.
→ Handle every aspect of Infusion including Prior authorization, cost, patient education, adherence
→ Experienced infusion staff to optimize follow up care, education and support for patients & families.
→ Significant cost savings compared to hospital or home based infusion
→ Benefits of experienced onsite specialized neuro & infusion care team while reducing burden of care & unnecessary cost at acute care facilities
Mahalo for trusting us since 2017 to provide optimal care model for neurological patients needing infusion in the setting of an integrated quality clinical care aligned with specialized infusion services. The outpatient ambulatory setting within a neuro-centric clinical care model improves patient care, as well as streamlining the process and making it much easier to respond to infusion reactions and to monitor and manage long-term side effect surveillance by a team of experienced neuroscience specialists.
Neurology
Neuroscience Chair
Director, Memory Disorders Center, Comprehensive Epilepsy Center, Neuro COVID Clinic, Center for Neuromodulation, Hawaii Pacific Neuroscience
Principal Investigator, Clinical Research Center, BRITL (Brain Research, Innovation & Translation Labs) BCI (Brain Computer Interface) & Brain Mapping Lab
Clinical Professor of Medicine (Neurology), Graduate Faculty, Clinical & Translational Research, University of Hawai`i John A. Burns School of Medicine
Our team is committed to reducing the disparity in health status of its racial and ethnic minority, rural, low-income, and other underserved populations. We have therefore focused our efforts in caring for underserved, minority, diverse patient populations. Click to review our commitment to Diversity, Equity and Inclusion and work undertaken by Center for Neuroscience Diversity especially for the Asian Americans and Native Hawaiian Pacific Islander Population (AANHPI).
